GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $187,125,000 | +160.9% | 862,727 | +38.8% | 3.32% | +111.6% |
| Q4 2020 | $71,711,000 | +96.3% | 621,361 | +65.5% | 1.57% | +35.5% |
| Q3 2020 | $36,540,000 | -38.0% | 375,344 | -21.8% | 1.16% | -44.5% |
| Q2 2020 | $58,923,000 | +45.6% | 480,145 | +3.9% | 2.09% | +11.3% |
| Q1 2020 | $40,479,000 | -18.0% | 462,247 | -2.1% | 1.88% | +9.3% |
| Q4 2019 | $49,392,000 | -17.8% | 472,378 | -9.6% | 1.72% | -20.6% |
| Q3 2019 | $60,094,000 | -39.5% | 522,419 | -9.3% | 2.16% | -31.6% |
| Q2 2019 | $99,346,000 | +447.4% | 576,287 | +202.7% | 3.16% | +270.4% |
| Q4 2018 | $18,150,000 | -0.8% | 190,396 | +10.1% | 0.85% | -23.0% |
| Q1 2018 | $18,302,000 | +466.1% | 172,891 | +617.0% | 1.11% | +376.0% |
| Q4 2017 | $3,233,000 | – | 24,112 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |